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Comments on "Trouble in
Paradise"
There are statements I wish to protest in the
Focus article "Trouble in Paradise" byJohn
F. Lauerman published in Environmental
Health Perspectives [105:914-917 (1997)].
These statements appear to have been
attributed to me, but I can assure you I
would neverhave made them.
First, there is the suggestion that I
included atrazine among alist ofagricultur-
al chemicals used in pineapple cultivation.
To my knowledge, atrazine was never used
on pineapple fields. It does appear in
Hawaiian groundwater, however, as a result
ofwidespread use on sugar cane fields.
Second, I would never say that "none
of these chemicals have been conclusively
linked to adverse health effects," as the
article appears to paraphrase me having
said. I believe that scientific studies conclu-
sively link all these chemicals, and still
more, with harmful health effects in
exposed populations. What I recall having
said to Lauerman is that it is almost impos-
sible to link, with any confidence, the can-
cer or other health problem of a given
individual with exposure to pesticides.
Thus, although a population may experi-
ence an increase in cancers or other health
problems in the aggregate, the likelihood
of a person with a cancer being able to
prove to the satisfaction of a court of law
that his or her disease was the result of
exposure to a chemical is vanishinglysmall.
The state of Hawaii has very serious
contamination problems as a result of the
application of agricultural chemicals and
other pesticide products. I do not wish to
have my statements be interpreted in any
way as minimizing this problem or my own
concern for thehealth risks that this poses.
Patricia Tummons
Environment Hawaii
Hilo, Hawaii
Note: Atrazine was mistakenly included in
the list ofagricultural chemicals used in
pineapple cultivation. EHP regrets theerror.
The o2u-Globulin Discussion
One ofthe most valuable things to emerge
from the recent series ofletters published in
EHPin connection with the proposed a2u-
globulin mechanism of male rat renal car-
cinogenesis was the title ofthe final letter in
the series by Melnick et al. (1)-"Weight of
Evidence Versus Weight of Speculation to
Evaluate the Hypothesis." This arresting
tidle made me realize, for the first time, that
evidence and speculation are usually
irretrievably confused in the Discussion sec-
tion of most papers, certainly in most of
mine. It would be useful ifall papers had a
formal discussion ofthe data presented, fol-
lowed by a separate section titled
"Speculative Significance of the Data."
When an issue assumes an importance in its
own right, as with the a2u-globulin contro-
versy, the way forward should be to list the
evidence for and against the hypothesis,
leading, in turn, to an estimate ofits likely
validity. Weak points in the hypothesis
would thereby be revealed, and these could
become the focus of further experiments;
alternatively, the hypothesis could be aban-
doned. This pathwas nottaken in the recent
debate and, as aconsequence, weareleftwith
opposingspeculations andno resolution.
I tookpart in the EPAreviewoftheax2u-
globulin mechanism referred to by several of
thediscussants in thisdebate, and mostofthe
data recendy discussed were reviewed at that
time. However, thetrend inthat meetingwas
to hear the opposing arguments and to then
drawacondusion-infact, speculations were
weighed, and the balance happened to come
out in favor ofthe probable validity of the
hypothesis. Whatwas missingfrom that exer-
cise was a dissection ofeach ofthe compo-
nentdatasets, leadingto adecision as to their
individual validity. That process was started
duringthecourseoftheEHPdebate.
The a2u-globulin mechanism of renal
carcinogenesis is among the richest in data
and speculation of all proposed nongeno-
toxic mechanisms ofrodent carcinogenesis.
It is therefore critical that advantage is taken
of the impetus provided by the recent
debate and that this hypothesis is reevaluat-
ed according to rigorous scientific criteria.
Apart from the obvious need to advance our
understanding ofthe potential carcinogenic
hazard implicit in this mechanism, there is
the subsidiary question ofwhether an agent
such as limonene is formally required to be
active in the TgAC and the p53 mouse
abbreviated carcinogenicity bioassays. As
things stand at the moment (2), a positive
result in both of these assays would define
limonene as a genotoxic carcinogen, where-
as a positive result in only the TgAC skin
painting assaywould define it as a nongeno-
toxic carcinogen. A negative result in both
assays would probably be rationalized along
the lines that limonene represents the type
of nongenotoxic carcinogen that modern
methods should not be required to detect,
i.e., that it should be classified as 'generally
regarded as safe" (2). In fact, the suggested
need for such abbreviated carcinogenicity
bioassays oflimonene would probably flow
from a full analysis of the a2u-globulin
hypothesis, but that, in turn, would imply
that these two assays are already confirmed
as giving mechanistically diagnostic data,
which theyare not. Thus, the importance of
resolving thea2u-globulin debate.
Science proceeds by way of informed
speculation. However, such speculations
should not become personal property to
defend at all costs. Rather, they should be
vigorously challenged with the aim ofeither
refuting them or transforming them into
generally accepted facts. The sooner that
happens with the speculations surrounding
the ax2u-globulin hypothesis, the better.
JohnAshby
Zeneca CTL
Alderley Park
Cheshire, United Kingdom
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Re: "A Pilot Study of Urinary
Estrogen Metabolites
(16cz-OHE1 and 2-OHE1) in
Postmenopausal Women with
and without Breast Cancer"
Ursinetal. (1) reportdataontheabsenceofa
difference in the 2-hydroxyestrone/l6a-
hydroxyestrone (2-OHE1/16a-OHE1) ratio
between breast cancer cases and controls.
These findings contrast with pilot data
recendy reported by Kabat et al. (2), indicat-
ingastrongandstatisticallysignificant inverse
association ofthe ratio with postmenopausal
breast cancer, as well as in other recently
reported studies (3). There are a number of
methodological aspects ofthe study by Ursin
etal. (1) thatrequirecomment.
First, although it is not explicitly stated,
the authors recontacted women who partic-
ipated in an earlier case-control study of
breast cancer (4) to obtain urine samples
from those qualified survivors who agreed
to participate. The cases had been diag-
nosed between March 1987 and December
1989 and were recontacted approximately
7 years later. In the original population-
based study, 1,510 matched case-control
pairs were interviewed. Only stage I and II
cases were included in that study. For the
urinary estrogen study, the authors estimat-
ed that 55-60% ofthe original participants
were excluded because they were receiving
chemotherapy or other medication or
weighed more than 200 pounds, which
might affect estrogen metabolism.
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